Sarah D. Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sarah D. Huang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Alexander R. Pelletier
NHLBI Integrated Cardiovascular Data Science Training Program, UCLA, Los Angeles, California 90095, United States
1 shared publicationAnna Furniss
ACCORDS, University of Colorado Aurora Colorado USA
1 shared publicationBaradwaj Simha Sankar
Departments of Physiology and Medicine, University of California, Los Angeles (UCLA) School of Medicine, Los Angeles, California 90095, United States
1 shared publicationBilal Mirza
Departments of Physiology and Medicine, University of California, Los Angeles (UCLA) School of Medicine, Los Angeles, California 90095, United States
1 shared publication- Casey R. Scherer
Perinatal Diagnostic Center, Lucile Packard Children’s Hospital, Palo Alto, USA
1 shared publication Chijioke Ikomi
Division of Endocrinology Nemours Children's Health Wilmington Delaware USA
1 shared publication
Latest Publications
- 18 November 2025
- Published by Springer Nature in Journal of Community Genetics
- Vol. 17 (1) , 2
Genetic exceptionalism and genomic contextualism among Asian Americans: a qualitative study
Views on genetic information — and how it compares to other health information — play a key role in shaping policy surrounding its treatment, management, and communication. Genetic exceptionalism and genomic contextualism are important frameworks to better understand how communities view genetic information in comparison to other medical data. This study aimed to explore how Asian Americans view genetic information and what factors influence their views. Using a qualitative study design guided by reflexive thematic analysis, we interviewed 20 ostensibly healthy Asian American adults about their attitudes toward and experiences with genetic information. We developed four themes: first, participants discussed diverse potential uses and qualities of genetic information that distinguished it from other types of health information, such as providing insight into future health conditions. However, they underscored the continued importance of other types of health information depending on context, and did not view genetic information as deterministic or the essence, giving weight to environmental contributors in molding who they are. Views on genetic information were shaped by complex, interacting factors at individual, family, and community or cultural levels, such as stigma, intersectional identities, and family dynamics. Participants had overall limited awareness of clinical genetics services and indications genetic testing could be offered for, despite high self-reported health literacy. Our participants’ views on genetic information were complex and context-dependent, in line with genomic contextualism. This should be considered in providing culturally-engaged genetics education and developing genomics policies that reflect how diverse communities truly feel about genetic information.
- 18 November 2025
- Published by Springer Nature in Journal of Community Genetics
- Vol. 17 (1) , 2
Genetic exceptionalism and genomic contextualism among Asian Americans: a qualitative study
Views on genetic information — and how it compares to other health information — play a key role in shaping policy surrounding its treatment, management, and communication. Genetic exceptionalism and genomic contextualism are important frameworks to better understand how communities view genetic information in comparison to other medical data. This study aimed to explore how Asian Americans view genetic information and what factors influence their views. Using a qualitative study design guided by reflexive thematic analysis, we interviewed 20 ostensibly healthy Asian American adults about their attitudes toward and experiences with genetic information. We developed four themes: first, participants discussed diverse potential uses and qualities of genetic information that distinguished it from other types of health information, such as providing insight into future health conditions. However, they underscored the continued importance of other types of health information depending on context, and did not view genetic information as deterministic or the essence, giving weight to environmental contributors in molding who they are. Views on genetic information were shaped by complex, interacting factors at individual, family, and community or cultural levels, such as stigma, intersectional identities, and family dynamics. Participants had overall limited awareness of clinical genetics services and indications genetic testing could be offered for, despite high self-reported health literacy. Our participants’ views on genetic information were complex and context-dependent, in line with genomic contextualism. This should be considered in providing culturally-engaged genetics education and developing genomics policies that reflect how diverse communities truly feel about genetic information.
- Open Access
- 27 August 2024
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 23 (9) , 4151-4162
Missing Values in Longitudinal Proteome Dynamics Studies: Making a Case for Data Multiple Imputation
Temporal proteomics data sets are often confounded by the challenges of missing values. These missing data points, in a time-series context, can lead to fluctuations in measurements or the omission of critical events, thus hindering the ability to fully comprehend the underlying biomedical processes. We introduce a Data Multiple Imputation (DMI) pipeline designed to address this challenge in temporal data set turnover rate quantifications, enabling robust downstream analysis to gain novel discoveries. To demonstrate its utility and generalizability, we applied this pipeline to two use cases: a murine cardiac temporal proteomics data set and a human plasma temporal proteomics data set, both aimed at examining protein turnover rates. This DMI pipeline significantly enhanced the detection of protein turnover rate in both data sets, and furthermore, the imputed data sets captured new representation of proteins, leading to an augmented view of biological pathways, protein complex dynamics, as well as biomarker-disease associations. Importantly, DMI exhibited superior performance in benchmark data sets compared to single imputation methods (DSI). In summary, we have demonstrated that this DMI pipeline is effective at overcoming challenges introduced by missing values in temporal proteome dynamics studies.
- 27 August 2024
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 23 (9) , 4151-4162
Open AccessMissing Values in Longitudinal Proteome Dynamics Studies: Making a Case for Data Multiple Imputation
Temporal proteomics data sets are often confounded by the challenges of missing values. These missing data points, in a time-series context, can lead to fluctuations in measurements or the omission of critical events, thus hindering the ability to fully comprehend the underlying biomedical processes. We introduce a Data Multiple Imputation (DMI) pipeline designed to address this challenge in temporal data set turnover rate quantifications, enabling robust downstream analysis to gain novel discoveries. To demonstrate its utility and generalizability, we applied this pipeline to two use cases: a murine cardiac temporal proteomics data set and a human plasma temporal proteomics data set, both aimed at examining protein turnover rates. This DMI pipeline significantly enhanced the detection of protein turnover rate in both data sets, and furthermore, the imputed data sets captured new representation of proteins, leading to an augmented view of biological pathways, protein complex dynamics, as well as biomarker-disease associations. Importantly, DMI exhibited superior performance in benchmark data sets compared to single imputation methods (DSI). In summary, we have demonstrated that this DMI pipeline is effective at overcoming challenges introduced by missing values in temporal proteome dynamics studies.
- 8 December 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (4)
Development and validation of a computable phenotype for Turner syndrome utilizing electronic health records from a national pediatric network
Turner syndrome (TS) is a genetic condition occurring in ~1 in 2000 females characterized by the complete or partial absence of the second sex chromosome. TS research faces similar challenges to many other pediatric rare disease conditions, with homogenous, single‐center, underpowered studies. Secondary data analyses utilizing electronic health record (EHR) have the potential to address these limitations; however, an algorithm to accurately identify TS cases in EHR data is needed. We developed a computable phenotype to identify patients with TS using PEDSnet, a pediatric research network. This computable phenotype was validated through chart review; true positives and negatives and false positives and negatives were used to assess accuracy at both primary and external validation sites. The optimal algorithm consisted of the following criteria: female sex, ≥1 outpatient encounter, and ≥3 encounters with a diagnosis code that maps to TS, yielding an average sensitivity of 0.97, specificity of 0.88, and C‐statistic of 0.93 across all sites. The accuracy of any estradiol prescriptions yielded an average C‐statistic of 0.91 across sites and 0.80 for transdermal and oral formulations separately. PEDSnet and computable phenotyping are powerful tools in providing large, diverse samples to pragmatically study rare pediatric conditions like TS.
- 8 December 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (4)
Development and validation of a computable phenotype for Turner syndrome utilizing electronic health records from a national pediatric network
Turner syndrome (TS) is a genetic condition occurring in ~1 in 2000 females characterized by the complete or partial absence of the second sex chromosome. TS research faces similar challenges to many other pediatric rare disease conditions, with homogenous, single‐center, underpowered studies. Secondary data analyses utilizing electronic health record (EHR) have the potential to address these limitations; however, an algorithm to accurately identify TS cases in EHR data is needed. We developed a computable phenotype to identify patients with TS using PEDSnet, a pediatric research network. This computable phenotype was validated through chart review; true positives and negatives and false positives and negatives were used to assess accuracy at both primary and external validation sites. The optimal algorithm consisted of the following criteria: female sex, ≥1 outpatient encounter, and ≥3 encounters with a diagnosis code that maps to TS, yielding an average sensitivity of 0.97, specificity of 0.88, and C‐statistic of 0.93 across all sites. The accuracy of any estradiol prescriptions yielded an average C‐statistic of 0.91 across sites and 0.80 for transdermal and oral formulations separately. PEDSnet and computable phenotyping are powerful tools in providing large, diverse samples to pragmatically study rare pediatric conditions like TS.